(14 days)
No
The device description and intended use focus on mechanical safety features and do not mention any computational or data-driven capabilities.
No
The device is a syringe for injecting insulin, which is a drug, not for directly treating a disease or condition itself.
No
The device is described as a safety syringe for the injection of insulin, designed to prevent needlestick injuries and reuse. Its intended use is for administering medication, not for diagnosing a condition or disease.
No
The device description clearly indicates it is a physical syringe with a needle, not a software-only product.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "injection of insulin into a patient" and to "prevent needlestick injuries." This describes a device used for administering a substance directly into the body, which is an in vivo application, not an in vitro (outside the body) diagnostic test.
- Device Description: The description details a "piston syringe" with a "permanently attached needle," consistent with a device for injection.
- Lack of IVD Characteristics: The text does not mention any components or functions related to analyzing samples (like blood, urine, etc.) or providing diagnostic information. There's no mention of reagents, test strips, or any form of analysis performed on a sample.
Therefore, the CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is a medical device for drug delivery and safety, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is a sterile, single-use, disposable and nonreusable, retractable safety syringe which is intended to provide a safe and reliable method for injection of insulin into a patient.
The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is also intended to prevent needlestick injuries. In addition, when the userbreaks the plunger, reuse of the syringe is prevented.
Product codes
MEG, FMF
Device Description
The Life-Shield Products, Inc., CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is a sterile, single use and disposable, 0.5cc/mL piston syringe, provided with a permanently attached needle in nine product configurations. The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is similar in appearance, size, materials operation, and purpose to the cited predicate device and other conventional single use, sterile, disposable syringes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The materials of construction, safety feature, and other functional and performance characteristics of CAREO Safety Syringe for U-100 Insulin 0.5cc/mL are identical to those for the other CAREO Safety Syringes. The material safety test, biocompatibility, and safety feature were already indicated, verified, and validated as shown in the previous 510(k) premarket notifications [K030976, K052397, K060208, and K061055]. Therefore, no new tests are necessary.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
K030976, K052397, K060208, K061055
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).
0
510(k) Premarket Notification for
AUG - 8 2007
Life-Shield Products, Inc. CAREO Safety Syringe for U-100 Insulin 0.5cc/mL (per 21 CFR807.92)
1. Sponsor
Life-Shield Products, Inc. 3Fl., No. 10, Wuchiuan 7th Rd., Wugu Industrial Park, Taipei 248 Taiwan, R.O.C. Contact Person: Mr. Hsiao, Chung-Chih Telephone: +886 2 2299 6033 Fax: +886 2 2299 6035 Date Prepared: July 15, 2007
2. Device Name
| Proprietary Name: | CAREO Safety Syringe for U-100 Insulin 0.5cc/mL |
|---|---|
| Common/Usual Name: | Syringe |
| Classification Code: | MEG |
| Classification Name: | Syringe, Antistick |
3. Predicate Device
- InsoSAFETM Bak'SNAP™ Retractable Insulin Safety Syringe (K050131) ●
- . CAREO Safety Syringe for U-100 Insulin (K061055)
4. Device Description
The Life-Shield Products, Inc., CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is a sterile, single use and disposable, 0.5cc/mL piston syringe, provided with a permanently attached needle in nine product configurations. The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is similar in appearance, size, materials operation, and purpose to the cited predicate device and other conventional single use, sterile, disposable syringes.
Appendix K- page 1
1
న్. Intended Use
The CAREO Safety Syringe for U-100 Insulin 0.5cc/ml, is a sterile, single-use, disposable and non-reusable, retractable safety syringe which is intended to provide a safe and reliable method for injection of insulin into a patient.
The CAREO Safety Syringe for U-100 Insulin 0.5cc/mI, is also intended to prevent needlestick injuries. In addition, when the user breaks the plunger, reuse of the syringe is prevented.
Technological Characteristics and Substantial Equivalence 6.
Life-Shield Products, Inc., makes a claim of substantial equivalence of the CAREO Safety Syringe for U-100 Insulin 0.5cc/mL to the InsoSAFE™ Bak'SNAP™ Retractable Insulin Safety Syringe (K050131) and CAREO Safety Syringe for U-100 Insulin (K061055) based on similarities in intended use, design, technological and operational characteristics. All are indicated for injecting fluids (insulin) into the body, while helping to reduce the risk of sharps injuries. All syringes are piston syringes that use permanently attached single lumen hypodermic needles. All syringes are provided sterile, single-use, and disposable. All syringes require the user to manually retract the needle-plunger into the syringe barrel, snap off the plunger rod, and discard the pieces.
7. Summary for testing of material and simulated use study
The materials of construction, safety feature, and other functional and performance characteristics of CAREO Safety Syringe for U-100 Insulin 0.5cc/mL are identical to those for the other CAREO Safety Syringes. The material safety test, biocompatibility, and safety feature were already indicated, verified, and validated as shown in the previous 510(k) premarket notifications [K030976, K052397, K060208, and K061055]. Therefore, no new tests are necessary.
2
Image /page/2/Picture/11 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle with three stripes forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle.
AUG - 8 2007
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Life-Shield Products, Incorporated C/O Ms. Rosina Robinson Senior Staff Consultant Medical Device Consultants, Incorporated 49 Plain Street North Attleboro, Massachusetts 02760
- Re: K072037
Trade/Device Name: CAREO Safety Syringe for U-100 Insulin 0.5cc/mL Regulation Number: 880,5860 Regulation Name: Piston Syringe Regulatory Class: II Product Code: MEG, FMF Dated: July 24, 2007 Received: July 25, 2007
Dear Ms. Robinson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 -Ms. Robinson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Chiu Lin, Ph.D.
Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K072037
Device Name: Life-Shield Products, Inc., CAREO Safety Syringe for U-1 00 Insulin 0.5cc/ML
Indications For Use:
The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is a sterile, single-use, disposable and nonreusable, retractable safety syringe which is intended to provide a safe and reliable method for injection of insulin into a patient.
The CAREO Safety Syringe for U-100 Insulin 0.5cc/mL is also intended to prevent needlestick injuries. In addition, when the userbreaks the plunger, reuse of the syringe is prevented.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use × (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Charles Becker Jr.
(Division Sign-Off) Civision Orgh Sthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K072203+